(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Meten EdtechX Education Group Ltd., Leap Therapeutics, and Target Hospitality Corp..

Rank Financial Asset Price Change Updated (EST)
1 Meten EdtechX Education Group Ltd. (METXW) 0.16 32.97% 2021-09-16 20:49:06
2 Leap Therapeutics (LPTX) 2.53 31.09% 2021-09-16 19:51:05
3 Target Hospitality Corp. (THWWW) 0.45 24.31% 2021-09-17 09:09:05
4 aTyr Pharma (LIFE) 10.26 20.42% 2021-09-16 19:07:07
5 Outlook Therapeutics (OTLKW) 0.20 13.48% 2021-09-17 00:26:26
6 Luokung Technology Corp (LKCO) 1.50 11.94% 2021-09-16 19:23:08
7 SmileDirectClub (SDC) 6.70 11.67% 2021-09-17 15:12:43
8 Phio Pharmaceuticals Corp. (PHIO) 2.18 10.66% 2021-09-17 01:42:46
9 ARC Document Solutions (ARC) 3.43 10.29% 2021-09-17 15:51:09
10 VerifyMe (VRME) 3.44 9.21% 2021-09-17 15:36:16

The three most active and biggest losers today are VerifyMe, Youngevity International, and Pareteum Corporation.

Rank Financial Asset Price Change Updated (EST)
1 VerifyMe (VRMEW) 1.10 -17.68% 2021-09-17 11:23:10
2 Youngevity International (YGYI) 0.11 -15.38% 2021-09-17 13:06:06
3 Pareteum Corporation (TEUM) 0.12 -13.79% 2021-09-17 08:47:06
4 OncoSec Medical Incorporated (ONCS) 2.00 -9.5% 2021-09-16 23:47:05
5 United States Steel (X) 23.36 -8% 2021-09-17 15:43:01
6 Vericity (VERY) 7.73 -7.65% 2021-09-17 10:46:10
7 Larimar Therapeutics (LRMR) 11.51 -7.48% 2021-09-16 19:54:56
8 Mid-Southern Bancorp (MSVB) 14.16 -7.39% 2021-09-16 21:46:05
9 LM Funding America (LMFA) 4.36 -7.23% 2021-09-16 19:31:39
10 NGM Biopharmaceuticals (NGM) 23.84 -7.02% 2021-09-16 22:41:05

Most Active Winners today

1. Meten EdtechX Education Group Ltd. (METXW) – 32.97%

NASDAQ Composite ended the session with Meten EdtechX Education Group Ltd. rising 32.97% to $0.16 on Friday while NASDAQ Composite fell 0.91% to $15,043.97.

Meten EdtechX Education Group Ltd.’s last close was $0.16, 2.32% below its 52-week high of $0.16.

Meten EdtechX Education Group Ltd.’s Stock Yearly Top and Bottom Value

Meten EdtechX Education Group Ltd.’s stock is valued at $0.16 at 17:32 EST, under its 52-week high of $0.16 and way above its 52-week low of $0.13.

More news about Meten EdtechX Education Group Ltd..

2. Leap Therapeutics (LPTX) – 31.09%

NASDAQ Composite ended the session with Leap Therapeutics jumping 31.09% to $2.53 on Friday while NASDAQ Composite slid 0.91% to $15,043.97.

Volume

Today’s last reported volume for Leap Therapeutics is 103163000 which is 5918.21% above its average volume of 1714180.

Leap Therapeutics’s last close was $2.53, 21.91% below its 52-week high of $3.24.

Leap Therapeutics’s Sales

Leap Therapeutics’s sales growth is 377.3% for the current quarter and a decline by 22.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 22.2% and a negative 44.4%, respectively.

Leap Therapeutics’s Stock Yearly Top and Bottom Value

Leap Therapeutics’s stock is valued at $2.53 at 17:32 EST, way below its 52-week high of $3.24 and way higher than its 52-week low of $1.33.

Leap Therapeutics’s Moving Average

Leap Therapeutics’s value is way higher than its 50-day moving average of $1.66 and way above its 200-day moving average of $1.74.

More news about Leap Therapeutics.

3. Target Hospitality Corp. (THWWW) – 24.31%

NASDAQ Composite ended the session with Target Hospitality Corp. jumping 24.31% to $0.45 on Friday while NASDAQ Composite fell 0.91% to $15,043.97.

Target Hospitality Corp.’s last close was $0.44, 4.33% below its 52-week high of $0.46.

Target Hospitality Corp.’s Stock Yearly Top and Bottom Value

Target Hospitality Corp.’s stock is valued at $0.45 at 17:32 EST, below its 52-week high of $0.46 and above its 52-week low of $0.44.

More news about Target Hospitality Corp..

4. aTyr Pharma (LIFE) – 20.42%

NASDAQ Composite ended the session with aTyr Pharma jumping 20.42% to $10.26 on Friday, following the last session’s upward trend. NASDAQ Composite slid 0.91% to $15,043.97, after five successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for aTyr Pharma is 50498000 which is 1186.11% above its average volume of 3926370.

aTyr Pharma’s last close was $10.26, 20.89% below its 52-week high of $12.97.

The company’s growth estimates for the current quarter is 13.2% and a drop 4.3% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

aTyr Pharma’s stock is considered to be oversold (<=20).

aTyr Pharma’s Stock Yearly Top and Bottom Value

aTyr Pharma’s stock is valued at $10.26 at 17:32 EST, way under its 52-week high of $12.97 and way higher than its 52-week low of $2.93.

aTyr Pharma’s Moving Average

aTyr Pharma’s worth is way higher than its 50-day moving average of $5.31 and way higher than its 200-day moving average of $4.65.

More news about aTyr Pharma.

5. Outlook Therapeutics (OTLKW) – 13.48%

NASDAQ Composite ended the session with Outlook Therapeutics jumping 13.48% to $0.20 on Friday, after five successive sessions in a row of losses. NASDAQ Composite slid 0.91% to $15,043.97, after five sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Outlook Therapeutics’s last close was $0.20, 0% under its 52-week high of $0.20.

Outlook Therapeutics’s Stock Yearly Top and Bottom Value

Outlook Therapeutics’s stock is valued at $0.20 at 17:32 EST, above its 52-week high of $0.20.

More news about Outlook Therapeutics.

6. Luokung Technology Corp (LKCO) – 11.94%

NASDAQ Composite ended the session with Luokung Technology Corp rising 11.94% to $1.50 on Friday, after five successive sessions in a row of losses. NASDAQ Composite fell 0.91% to $15,043.97, after five sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Luokung Technology Corp is 43921200 which is 506.09% above its average volume of 7246580.

Luokung Technology Corp’s last close was $1.50, 61.14% under its 52-week high of $3.86.

Luokung Technology Corp’s Revenue

Year-on-year quarterly revenue growth declined by 16.1%, now sitting on 18.26M for the twelve trailing months.

Luokung Technology Corp’s Stock Yearly Top and Bottom Value

Luokung Technology Corp’s stock is valued at $1.50 at 17:32 EST, way below its 52-week high of $3.86 and way above its 52-week low of $0.38.

Luokung Technology Corp’s Moving Average

Luokung Technology Corp’s value is above its 50-day moving average of $1.43 and below its 200-day moving average of $1.51.

More news about Luokung Technology Corp.

7. SmileDirectClub (SDC) – 11.67%

NASDAQ Composite ended the session with SmileDirectClub rising 11.67% to $6.70 on Friday while NASDAQ Composite fell 0.91% to $15,043.97.

Volume

Today’s last reported volume for SmileDirectClub is 137680000 which is 1477.19% above its average volume of 8729450.

SmileDirectClub’s last close was $5.66, 64.8% under its 52-week high of $16.08.

SmileDirectClub’s Sales

SmileDirectClub’s sales growth is 25.6% for the present quarter and 10% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 18.2% and a negative 33.3%, respectively.

SmileDirectClub’s Revenue

Year-on-year quarterly revenue growth grew by 62.7%, now sitting on 726.7M for the twelve trailing months.

SmileDirectClub’s Stock Yearly Top and Bottom Value

SmileDirectClub’s stock is valued at $6.70 at 17:32 EST, way below its 52-week high of $16.08 and way above its 52-week low of $4.63.

SmileDirectClub’s Moving Average

SmileDirectClub’s worth is way above its 50-day moving average of $5.65 and way below its 200-day moving average of $8.36.

More news about SmileDirectClub.

8. Phio Pharmaceuticals Corp. (PHIO) – 10.66%

NASDAQ Composite ended the session with Phio Pharmaceuticals Corp. jumping 10.66% to $2.18 on Friday, following the last session’s upward trend. NASDAQ Composite fell 0.91% to $15,043.97, after five successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Phio Pharmaceuticals Corp. is 11349600 which is 3563.84% above its average volume of 309774.

Phio Pharmaceuticals Corp.’s last close was $2.05, 52.98% below its 52-week high of $4.36.

The company’s growth estimates for the present quarter and the next is 26.5% and 30%, respectively.

Phio Pharmaceuticals Corp.’s Stock Yearly Top and Bottom Value

Phio Pharmaceuticals Corp.’s stock is valued at $2.18 at 17:32 EST, way under its 52-week high of $4.36 and way higher than its 52-week low of $1.57.

Phio Pharmaceuticals Corp.’s Moving Average

Phio Pharmaceuticals Corp.’s value is way above its 50-day moving average of $1.87 and under its 200-day moving average of $2.23.

More news about Phio Pharmaceuticals Corp..

9. ARC Document Solutions (ARC) – 10.29%

NYSE Composite ended the session with ARC Document Solutions jumping 10.29% to $3.43 on Friday while NYSE Composite dropped 0.7% to $16,460.35.

Volume

Today’s last reported volume for ARC Document Solutions is 835647 which is 329.97% above its average volume of 194350.

ARC Document Solutions’s last close was $2.68, 21.87% below its 52-week high of $3.43.

ARC Document Solutions’s Sales

ARC Document Solutions’s sales growth is 1.3% for the present quarter and 0.4% for the next.

ARC Document Solutions’s Revenue

Year-on-year quarterly revenue growth grew by 7%, now sitting on 267.25M for the twelve trailing months.

ARC Document Solutions’s Stock Yearly Top and Bottom Value

ARC Document Solutions’s stock is valued at $3.43 at 17:32 EST, way below its 52-week low of $0.86.

ARC Document Solutions’s Moving Average

ARC Document Solutions’s value is way higher than its 50-day moving average of $2.66 and way above its 200-day moving average of $2.28.

More news about ARC Document Solutions.

10. VerifyMe (VRME) – 9.21%

NASDAQ Composite ended the session with VerifyMe jumping 9.21% to $3.44 on Friday, following the last session’s downward trend. NASDAQ Composite fell 0.91% to $15,043.97, after five consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for VerifyMe is 121102 which is 232.99% above its average volume of 36368.

VerifyMe’s last close was $3.85, 39.84% below its 52-week high of $6.40.

VerifyMe’s Sales

VerifyMe’s sales growth is 98% for the current quarter and 300% for the next.

VerifyMe’s Revenue

Year-on-year quarterly revenue growth grew by 104.3%, now sitting on 439k for the twelve trailing months.

VerifyMe’s Stock Yearly Top and Bottom Value

VerifyMe’s stock is valued at $3.44 at 17:32 EST, way below its 52-week high of $6.40 and way above its 52-week low of $2.29.

VerifyMe’s Moving Average

VerifyMe’s value is under its 50-day moving average of $3.66 and way below its 200-day moving average of $3.89.

More news about VerifyMe.

Most Active Losers Today

1. VerifyMe (VRMEW) – -17.68%

NASDAQ Composite ended the session with VerifyMe sliding 17.68% to $1.10 on Friday while NASDAQ Composite dropped 0.91% to $15,043.97.

VerifyMe’s last close was $1.34, 8.06% higher than its 52-week high of $1.24.

VerifyMe’s Stock Yearly Top and Bottom Value

VerifyMe’s stock is valued at $1.10 at 17:32 EST, below its 52-week low of $1.10.

More news about VerifyMe.

2. Youngevity International (YGYI) – -15.38%

NASDAQ Composite ended the session with Youngevity International sliding 15.38% to $0.11 on Friday while NASDAQ Composite slid 0.91% to $15,043.97.

Volume

Today’s last reported volume for Youngevity International is 9515 which is 61.05% below its average volume of 24432.

Youngevity International’s last close was $0.13, 87.5% under its 52-week high of $1.04.

Youngevity International’s Sales

Youngevity International’s sales growth is 3% for the current quarter and a decline by 23.1% for the next.

Youngevity International’s Revenue

Year-on-year quarterly revenue growth declined by 13%, now sitting on 147.44M for the twelve trailing months.

Youngevity International’s Stock Yearly Top and Bottom Value

Youngevity International’s stock is valued at $0.11 at 17:32 EST, way under its 52-week high of $1.04 and above its 52-week low of $0.11.

Youngevity International’s Moving Average

Youngevity International’s worth is way below its 50-day moving average of $0.20 and way below its 200-day moving average of $0.30.

More news about Youngevity International.

3. Pareteum Corporation (TEUM) – -13.79%

NASDAQ Composite ended the session with Pareteum Corporation sliding 13.79% to $0.12 on Friday while NASDAQ Composite fell 0.91% to $15,043.97.

Volume

Today’s last reported volume for Pareteum Corporation is 9901 which is 97.55% below its average volume of 405764.

Pareteum Corporation’s last close was $0.14, 84.09% under its 52-week high of $0.88.

Pareteum Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 22.9%, now sitting on 65.05M for the twelve trailing months.

Pareteum Corporation’s Stock Yearly Top and Bottom Value

Pareteum Corporation’s stock is valued at $0.12 at 17:32 EST, way below its 52-week high of $0.88 and way above its 52-week low of $0.09.

Pareteum Corporation’s Moving Average

Pareteum Corporation’s worth is way below its 50-day moving average of $0.21 and way under its 200-day moving average of $0.36.

More news about Pareteum Corporation.

4. OncoSec Medical Incorporated (ONCS) – -9.5%

NASDAQ Composite ended the session with OncoSec Medical Incorporated sliding 9.5% to $2.00 on Friday while NASDAQ Composite dropped 0.91% to $15,043.97.

Volume

Today’s last reported volume for OncoSec Medical Incorporated is 190809 which is 88.97% below its average volume of 1730530.

OncoSec Medical Incorporated’s last close was $2.00, 75.49% below its 52-week high of $8.16.

The company’s growth estimates for the present quarter is a negative 16% and positive 34.7% for the next.

OncoSec Medical Incorporated’s Stock Yearly Top and Bottom Value

OncoSec Medical Incorporated’s stock is valued at $2.00 at 17:32 EST, way below its 52-week high of $8.16 and higher than its 52-week low of $1.84.

OncoSec Medical Incorporated’s Moving Average

OncoSec Medical Incorporated’s worth is below its 50-day moving average of $2.19 and way under its 200-day moving average of $3.66.

More news about OncoSec Medical Incorporated.

5. United States Steel (X) – -8%

NYSE Composite ended the session with United States Steel sliding 8% to $23.36 on Friday while NYSE Composite fell 0.7% to $16,460.35.

Volume

Today’s last reported volume for United States Steel is 51159800 which is 154.98% above its average volume of 20063900.

United States Steel’s last close was $27.33, 10.6% under its 52-week high of $30.57.

United States Steel’s Sales

United States Steel’s sales growth is 153% for the ongoing quarter and 100.7% for the next. The company’s growth estimates for the current quarter and the next is 490.9% and 1607.4%, respectively.

United States Steel’s Revenue

Year-on-year quarterly revenue growth grew by 140.3%, now sitting on 13.59B for the twelve trailing months.

United States Steel’s Stock Yearly Top and Bottom Value

United States Steel’s stock is valued at $23.36 at 17:32 EST, way below its 52-week high of $30.57 and way higher than its 52-week low of $6.85.

United States Steel’s Moving Average

United States Steel’s value is way under its 50-day moving average of $26.75 and below its 200-day moving average of $24.44.

More news about United States Steel.

6. Vericity (VERY) – -7.65%

NASDAQ Composite ended the session with Vericity dropping 7.65% to $7.73 on Friday, after two successive sessions in a row of gains. NASDAQ Composite fell 0.91% to $15,043.97, after five sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Vericity is 6415 which is 52.9% below its average volume of 13621.

Vericity’s last close was $9.44, 57.15% under its 52-week high of $22.03.

Vericity’s Revenue

Year-on-year quarterly revenue growth grew by 19.9%, now sitting on 161.06M for the twelve trailing months.

Vericity’s Stock Yearly Top and Bottom Value

Vericity’s stock is valued at $7.73 at 17:32 EST, way below its 52-week high of $22.03 and above its 52-week low of $7.28.

Vericity’s Moving Average

Vericity’s value is way below its 50-day moving average of $9.11 and way under its 200-day moving average of $9.64.

More news about Vericity.

7. Larimar Therapeutics (LRMR) – -7.48%

NASDAQ Composite ended the session with Larimar Therapeutics falling 7.48% to $11.51 on Friday while NASDAQ Composite slid 0.91% to $15,043.97.

Volume

Today’s last reported volume for Larimar Therapeutics is 110073 which is 18.57% below its average volume of 135184.

Larimar Therapeutics’s last close was $11.51, 55.51% under its 52-week high of $25.87.

The company’s growth estimates for the present quarter and the next is 71.9% and 34.8%, respectively.

Larimar Therapeutics’s Stock Yearly Top and Bottom Value

Larimar Therapeutics’s stock is valued at $11.51 at 17:32 EST, way below its 52-week high of $25.87 and way higher than its 52-week low of $7.00.

Larimar Therapeutics’s Moving Average

Larimar Therapeutics’s value is way under its 50-day moving average of $12.83 and below its 200-day moving average of $12.53.

More news about Larimar Therapeutics.

8. Mid-Southern Bancorp (MSVB) – -7.39%

NASDAQ Composite ended the session with Mid-Southern Bancorp dropping 7.39% to $14.16 on Friday, following the last session’s downward trend. NASDAQ Composite dropped 0.91% to $15,043.97, after five successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Mid-Southern Bancorp is 248 which is 91.92% below its average volume of 3073.

Mid-Southern Bancorp’s last close was $14.16, 14.65% under its 52-week high of $16.59.

Mid-Southern Bancorp’s Revenue

Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 7.58M for the twelve trailing months.

Mid-Southern Bancorp’s Stock Yearly Top and Bottom Value

Mid-Southern Bancorp’s stock is valued at $14.16 at 17:32 EST, way under its 52-week high of $16.59 and way higher than its 52-week low of $12.38.

Mid-Southern Bancorp’s Moving Average

Mid-Southern Bancorp’s worth is under its 50-day moving average of $15.43 and under its 200-day moving average of $15.48.

More news about Mid-Southern Bancorp.

9. LM Funding America (LMFA) – -7.23%

NASDAQ Composite ended the session with LM Funding America dropping 7.23% to $4.36 on Friday while NASDAQ Composite fell 0.91% to $15,043.97.

Volume

Today’s last reported volume for LM Funding America is 201173 which is 87.79% below its average volume of 1648270.

LM Funding America’s last close was $4.36, 76.43% below its 52-week high of $18.50.

LM Funding America’s Revenue

Year-on-year quarterly revenue growth declined by 45.6%, now sitting on 711.03k for the twelve trailing months.

LM Funding America’s Stock Yearly Top and Bottom Value

LM Funding America’s stock is valued at $4.36 at 17:32 EST, way below its 52-week high of $18.50 and way above its 52-week low of $2.42.

LM Funding America’s Moving Average

LM Funding America’s value is under its 50-day moving average of $4.78 and way below its 200-day moving average of $5.14.

More news about LM Funding America.

10. NGM Biopharmaceuticals (NGM) – -7.02%

NASDAQ Composite ended the session with NGM Biopharmaceuticals dropping 7.02% to $23.84 on Friday while NASDAQ Composite dropped 0.91% to $15,043.97.

Volume

Today’s last reported volume for NGM Biopharmaceuticals is 916967 which is 151.53% above its average volume of 364555.

NGM Biopharmaceuticals’s last close was $23.84, 25.78% under its 52-week high of $32.12.

The company’s growth estimates for the current quarter and the next is 18.6% and 7.5%, respectively.

NGM Biopharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 15.1%, now sitting on 81.6M for the twelve trailing months.

NGM Biopharmaceuticals’s Stock Yearly Top and Bottom Value

NGM Biopharmaceuticals’s stock is valued at $23.84 at 17:32 EST, way below its 52-week high of $32.12 and way above its 52-week low of $14.90.

NGM Biopharmaceuticals’s Moving Average

NGM Biopharmaceuticals’s worth is higher than its 50-day moving average of $22.30 and above its 200-day moving average of $23.76.

More news about NGM Biopharmaceuticals.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here